アボットラボは2025年1月1日,Q2の1株当たり1.30ドルを獲得し,期待に応え,収入は6.9%上昇した. Abbott Labs earned $1.30 per share in Q2 2025, met expectations, with revenue up 6.9% year-over-year.

アボット研究所は2025年第2四半期に1株当たり1.30ドルの利益を報告し,予想を満たし,11.37億ドルの収益で,同比6.9%増加した. Abbott Laboratories reported second-quarter 2025 earnings of $1.30 per share, meeting expectations, with revenue of $11.37 billion, up 6.9% year-over-year. 同社は2025年全年のEPSの予測を5.12ドル/5.18ドルに上げ, 31.88%の純利益率と17.78%の資本収益率で高い収益性を維持した. The company raised its full-year 2025 EPS guidance to $5.12–$5.18, maintaining strong profitability with a 31.88% net margin and 17.78% return on equity. 株式は128.69ドルで取引されているが,市場資本は223.98億円,p/e比は16.13ドルである. The stock, trading at $128.69, has a market cap of $223.98 billion and a P/E ratio of 16.13. 分析者は147.61ドルの目標で"適度な買い"と評価し,同社は1株当たり0.59ドルの四半期配当を発表した. Analysts rate it a "Moderate Buy" with a $147.61 target, and the company declared a quarterly dividend of $0.59 per share. 組織の所有権は75.18%に保たれている. Institutional ownership remains high at 75.18%.